Skip to main content
. 2024 Jul 9;8(16):4410–4413. doi: 10.1182/bloodadvances.2024013182

Figure 1.

Figure 1.

OS and DFS of the study population and of IR patients. (A-B) Six-year OS (A) and DFS (B) by risk category. (C-D) 6-year OS (C) and DFS (D) in IR patients MRD-negative (<0.035%) for the blue curve and MRD-positive (>0.035%) for the yellow one.